Artelo Biosciences, Inc. (ARTL)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.91
- As of
Kresmion compiles this page from ARTL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ARTELO BIOSCIENCES, INC. (ARTL): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-09.
See the full ARTL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ARTL on one page. Preview it with sample data, then open it live with a free account.
Preview the ARTL dossierActive events for ARTL
- mediumEarnings below estimates
Q1-2025: Missed consensus by 443.0% - EPS $-12.96 vs $-2.3868 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 31.3% - EPS $-16.83 vs $-12.8214 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 374.7% - EPS $-11.91 vs $-2.5092 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 97.5% - EPS $-0.12 vs $-4.8042 estimate
FREE, NO ACCOUNT
Every event on ARTL, as it fires
New filings, 13F moves and cross asset events on ARTL land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, ARTL
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
ARTL's 10-Q filed Aug 12, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on ARTL
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in ARTL on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ARTL in the last 180 days.
Upstream: SEC EDGAR filings for ARTL
Kresmion, "ARTELO BIOSCIENCES, INC. (ARTL) institutional holdings and SEC filings", data as of 2026-10-09, https://kresmion.com/research/ARTL. Upstream data: SEC EDGAR filings for ARTL.
Link to this data (HTML):
<a href="https://kresmion.com/research/ARTL">ARTELO BIOSCIENCES, INC. (ARTL) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow ARTL on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ARTL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.